1. Market Research
  2. > Biotechnology
  3. > Genomics Market Trends
  4. > In situ Hybridization Market by Type, Application, End User & by Geography - Analysis and Forecast to 2019

In-situ hybridization (ISH) is a powerful technique used for focusing on specific nucleic acid targets within fixed tissues and cells, to obtain temporal and spatial information about gene expression. The in-situ hybridization technique is divided into two types, namely DNA and RNA. This is because, normally ISH requires isolation of DNA or RNA which is done by separating it on a gel, blotting it onto nitrocellulose, and probing it with a complementary sequence.

The global in-situ hybridization market was valued at $554.4 million 2014, and is estimated to reach $681.0 million by 2019, at a CAGR of 4.2% from 2014 to 2019.

The global in-situ hybridization market is primarily driven by the increasing prevalence of cancer disease, growing usage of personalized medicines for its treatment, and rising number of initiatives undertaken by the government, such as create awareness about cancer and providing funding to support related researches.

The report includes company profiles of major players, recent activities in the market, new product launches, mergers & acquisitions, collaborations and partnerships, and SWOT analysis.

Some of the companies profiled in this report are Abbott (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Affymetrix, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), and Agilent Technologies, Inc. (U.S.).

Reasons to Buy the Report:

From an insight perspective, this research report has focused on various levels of analysis—industry analysis (industry trends, and PEST analysis), market share analysis of top players, supply chain analysis, and company profiles, which together comprise and discuss the basic views on the competitive landscape, usage patterns, emerging- and high-growth segments of the global in-situ hybridization market, high-growth regions and countries and their respective regulatory policies, government initiatives, drivers, restraints, and opportunities.

The report will enrich both established firms as well as new entrants/smaller firms to analyze the market, which in turn will help the firms in achieving greater market share. Firms purchasing the report could use any one or combination of the below mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market share.

The report provides insights on the following pointers:

- Product Analysis and development: Detailed insights on upcoming technologies, research and development activities, and new product launches in the global in-situ hybridization market. Usage pattern/ penetration rate (in-depth trend analysis) of products (Segment wise) and purchasing data. Comprehensive coverage of product approvals, pipeline products, and product recalls.
- Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for in-situ hybridization across geographies, exploit new distribution channels, new clientele base, and different pricing policies.
- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments decisions in the global in-situ hybridization market. Detailed description regarding the related and unrelated diversification pertaining to this market.
- Competitive Assessment: In-depth assessment of market shares, company share analysis of the key players forecasted till 2019. Develop business strategies and manufacturing capabilities of leading players enhance the bottom line of the companies operational in the global in-situ hybridization market.

Table Of Contents

In situ Hybridization Market by Type, Application, End User and by Geography - Analysis and Forecast to 2019
TABLE OF CONTENTS

1. INTRODUCTION
2. EXECUTIVE SUMMARY
3. MARKET OVERVIEW
4 MARKET DYNAMICS
5 IN-SITU HYBRIDIZATION MARKET, BY TYPE
6 IN-SITU HYBRIDIZATION MARKET, BY APPLICATION
7 IN-SITU HYBRIDIZATION MARKET, BY END USER
8 IN-SITU HYBRIDIZATION MARKET, BY GEOGRAPHY
9 COMPETITIVE LANDSCAPE
10 COMPANY PROFILES
10.1 ABBOTT
10.2 BIOGENEX
10.3 BIOSB
10.4 F. HOFFMANN-LA ROCHE LTD
10.5 SIGMA-ALDRICH CO. LLC.
10.6 ADVANCED CELL DIAGNOSTICS
10.7 AFFYMETRIX, INC.
10.8 EXIQON A/S
10.9 AGILENT TECHNOLOGIES
10.10 THERMO FISHER SCIENTIFIC, INC.
11 APPENDIX


LIST OF TABLES


5.1 IN-SITU HYBRIDIZATION MARKET, BY TYPE, 2012-2019 (USD MN)
5.2 DNA IN-SITU HYBRIDIZATION MARKET, BY GEOGRAPHY, 2012-2019 (USD MN)
5.3 DNA FLUORESCENT IN-SITU HYBRIDIZATION MARKET, BY GEOGRAPHY,
2012-2019 (USD MN)
5.4 DNA CHROMOGENIC IN-SITU HYBRIDIZATION MARKET, BY GEOGRAPHY,
2012-2019 (USD MN)
5.5 RNA IN-SITU HYBRIDIZATION MARKET, BY GEOGRAPHY, 2012-2019 (USD MN)
5.6 RNA FLUORESCENT IN-SITU HYBRIDIZATION (FISH) MARKET, BY GEOGRAPHY,
2012-2019 (USD MN)
5.7 RNA CHROMOGENIC IN-SITU HYBRIDIZATION (CISH) MARKET, BY GEOGRAPHY,
2012-2019 (USD MN)
6.1 IN-SITU HYBRIDIZATION MARKET, BY APPLICATION, 2012-2019 (USD MN)
6.2 CANCER DIAGNOSTICS MARKET, BY GEOGRAPHY, 2012-2019 (USD MN)
6.3 CYTOLOGY MARKET, BY GEOGRAPHY, 2012-2019 (USD MN)
6.4 NEUROSCIENCE MARKET, BY GEOGRAPHY, 2012-2019 (USD MN)
6.5 IMMUNOLOGY MARKET, BY GEOGRAPHY, 2012-2019 (USD MN)
6.6 OTHER APPLICATIONS MARKET, BY GEOGRAPHY, 2012-2019 (USD MN)
7.1 IN-SITU HYBRIDIZATION MARKET, BY END USER, 2012 - 2019 (USD MN)
7.2 HOSPITAL MARKET, BY GEOGRAPHY, 2012-2019 (USD MN)
7.3 PHARMA and BIOTECH COMPANIES MARKET, BY GEOGRAPHY, 2012-2019 (USD MN)
7.4 RESEARCH LABS MARKET, BY GEOGRAPHY, 2012-2019 (USD MN)
7.5 CROS MARKET, BY GEOGRAPHY, 2012-2019 (USD MN)
7.6 OTHER END USER MARKET, BY GEOGRAPHY, 2012-2019 (USD MN)
8.1 IN-SITU HYBRIDIZATION MARKET, BY GEOGRAPHY, 2012-2019 (USD MN)
8.2 NORTH AMERICA IN-SITU HYBRIDIZATION MARKET, BY TYPE, 2012-2019 (USD MN)
8.3 NORTH AMERICA DNA IN-SITU HYBRIDIZATION MARKET, BY TECHNIQUE,
2012-2019 (USD MN)
8.4 NORTH AMERICA RNA IN-SITU HYBRIDIZATION MARKET, BY TECHNIQUE,
2012-2019 (USD MN)
8.5 NORTH AMERICA IN-SITU HYBRIDIZATION MARKET, BY APPLICATION,
2012-2019 (USD MN)
8.6 NORTH AMERICA IN-SITU HYBRIDIZATION MARKET, BY END USER,
2012-2019 (USD MN)
8.7 EUROPE IN-SITU HYBRIDIZATION MARKET, BY TYPE, 2012-2019 (USD MN)
8.8 EUROPE DNA IN-SITU HYBRIDIZATION MARKET, BY TECHNIQUE,
2012-2019 (USD MN)
8.9 EUROPE RNA IN-SITU HYBRIDIZATION MARKET, BY TECHNIQUE,
2012-2019 (USD MN)
8.10 EUROPE IN-SITU HYBRIDIZATION MARKET, BY APPLICATION, 2012-2019 (USD MN)
8.11 EUROPE IN-SITU HYBRIDIZATION MARKET, BY END USER, 2012- 2019 (USD MN)
8.12 APAC IN-SITU HYBRIDIZATION MARKET, BY TYPE, 2012- 2019 (USD MN)
8.13 APAC DNA IN-SITU HYBRIDIZATION MARKET, BY TECHNIQUE,
2012- 2019 (USD MN)
8.14 APAC RNA IN-SITU HYBRIDIZATION MARKET, BY TECHNIQUE, 2012-2019 (USD MN)
8.15 APAC IN-SITU HYBRIDIZATION MARKET, BY APPLICATION, 2012-2019 (USD MN)
8.16 APAC IN-SITU HYBRIDIZATION MARKET, BY END USER, 2012-2019 (USD MN)
8.17 ROW IN-SITU HYBRIDIZATION MARKET, BY TYPE, 2012- 2019 (USD MN)
8.18 ROW DNA IN-SITU HYBRIDIZATION MARKET, BY TECHNIQUE, 2012-2019 (USD MN)
8.19 ROW RNA IN-SITU HYBRIDIZATION MARKET, BY TECHNIQUE, 2012-2019 (USD MN)
8.20 ROW IN-SITU HYBRIDIZATION MARKET, BY APPLICATION, 2012-2019 (USD MN)
8.21 ROW IN-SITU HYBRIDIZATION MARKET, BY END USER, 2012- 2019 (USD MN)


LIST OF FIGURES

2.1 IN-SITU HYBRIDIZATION MARKET SIZE, 2014 and 2019
2.2 IN-SITU HYBRIDIZATION MARKET SIZE, 2014 and 2019
2.3 IN-SITU HYBRIDIZATION MARKET SIZE, 2014 and 2019
3.1 IN-SITU HYBRIDIZATION MARKET SIZE, 2014 and 2019 (USD MN)
3.2 IN-SITU HYBRIDIZATION MARKET, BY TYPE, 2014 and 2019 (USD MN)
3.3 DNA IN-SITU HYBRIDIZATION MARKET, BY TECHNIQUE, 2014 and 2019 (USD MN)
3.4 RNA IN-SITU HYBRIDIZATION MARKET, BY TECHNIQUE, 2014 and 2019 (USD MN)
3.5 IN-SITU HYBRIDIZATION MARKET, BY APPLICATION, 2014 and 2019 (USD MN)
3.6 IN-SITU HYBRIDIZATION MARKET, BY END-USER, 2014 and 2019 (USD MN)
5.1 IN-SITU HYBRIDIZATION MARKET, BY TYPE, 2014 and 2019 (USD MN)
5.2 DNA IN-SITU HYBRIDIZATION MARKET, BY GEOGRAPHY, 2012 - 2019 (USD MN)
5.3 DNA FLUORESCENT IN-SITU HYBRIDIZATION MARKET, BY GEOGRAPHY,
2012 - 2019 (USD MN)
5.4 DNA CHROMOGENIC IN-SITU HYBRIDIZATION MARKET, BY GEOGRAPHY,
2012 - 2019 (USD MN)
5.5 RNA IN-SITU HYBRIDIZATION MARKET, BY GEOGRAPHY, 2012 - 2019 (USD MN)
5.6 RNA FLUORESCENT IN-SITU HYBRIDIZATION (FISH) MARKET, BY GEOGRAPHY, 2012 - 2019 (USD MN)
5.7 RNA CHROMOGENIC IN-SITU HYBRIDIZATION (CISH) MARKET, BY GEOGRAPHY, 2012 - 2019 (USD MN)
6.1 IN-SITU HYBRIDIZATION MARKET, BY APPLICATION, 2014 and 2019 (USD MN)
6.2 IN-SITU HYBRIDIZATION MARKET, BY APPLICATION, 2014 and 2019 (USD MN)
6.3 CANCER DIAGNOSTICS MARKET, BY GEOGRAPHY, 2012 - 2019 (USD MN)
6.4 CYTOLOGY MARKET, BY GEOGRAPHY, 2012 - 2019 (USD MN)
6.5 NEUROSCIENCE MARKET, BY GEOGRAPHY, 2012 - 2019 (USD MN)
6.6 IMMUNOLOGY MARKET, BY GEOGRAPHY, 2012 - 2019 (USD MN)
6.7 OTHER APPLICATION MARKET, BY GEOGRAPHY, 2012 - 2019 (USD MN)
7.1 IN-SITU HYBRIDIZATION MARKET, BY END USER, 2012 - 2019 (USD MN)
7.2 END-USER MARKET, BY GEOGRAPHY, 2014 and 2019 (USD MN)
7.3 HOSPITALS MARKET, BY GEOGRAPHY, 2012 - 2019 (USD MN)
7.4 PHARMA and BIOTECH COMPANIES MARKET, BY GEOGRAPHY,
2012 - 2019 (USD MN)
7.5 RESEARCH LABS MARKET, BY GEOGRAPHY, 2012 - 2019 (USD MN)
7.6 CROS MARKET, BY GEOGRAPHY, 2012 - 2019 (USD MN)
7.7 OTHERS MARKET, BY GEOGRAPHY, 2012 - 2019 (USD MN)
8.1 IN-SITU HYBRIDIZATION MARKET, BY GEOGRAPHY, 2012 - 2019 (USD MN)
8.2 NORTH AMERICA IN-SITU HYBRIDIZATION MARKET, 2014 and 2019 (%)
8.3 EUROPE IN-SITU HYBRIDIZATION MARKET, 2014 and 2019 (%)
8.4 APAC IN-SITU HYBRIDIZATION MARKET, 2014 and 2019 (%)
8.5 ROW IN-SITU HYBRIDIZATION MARKET, 2014 and 2019 (%)

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
RNA Sequencing - Patent Overview (Last 5 years)

RNA Sequencing - Patent Overview (Last 5 years)

  • $ 2000
  • Industry report
  • November 2016
  • by Mordor Intelligence LLP

RNA sequencing (RNA-Seq) is an evolving, highly sensitive and accurate tool that uses deep-sequencing technologies (next-generation sequencing) for transcriptome profiling. It is more sensitive, more robust ...

DNA-Dependent RNA Polymerase Inhibitors -Pipeline Insights, 2016

DNA-Dependent RNA Polymerase Inhibitors -Pipeline Insights, 2016

  • $ 1250
  • Industry report
  • November 2016
  • by Delve Insight

DelveInsight’s, “DNA-Dependent RNA Polymerase Inhibitors-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the DNA-Dependent ...

Viral RNA Polymerase Inhibitors -Pipeline Insights, 2016

Viral RNA Polymerase Inhibitors -Pipeline Insights, 2016

  • $ 1250
  • Industry report
  • November 2016
  • by Delve Insight

DelveInsight’s, “Viral RNA Polymerase Inhibitors-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Viral RNA Polymerase ...

Global Biobanks Market

October 2016 $ 4250

ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.